GTx 024

Known as: Gtx-024 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2017
012319852017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Stress urinary incontinence (SUI), a prevalent condition, is represented by an involuntary leakage of urine that results, at… (More)
Is this relevant?
Review
2017
Review
2017
Background Cancer cachexia impacts the majority of advanced cancer patients but no approved anticachexia therapeutic exits… (More)
  • table 1
Is this relevant?
2016
2016
GTx-024 (also known as enobosarm) is a first in class selective androgen receptor modulator being developed for diverse… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
2015
2015
Androgens increase skeletal muscle mass, but their clinical use is hampered by a lack of tissue selectivity and subsequent side… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2014
Review
2014
Muscle loss and wasting occurs with aging and in multiple disease states including cancer, heart failure, chronic obstructive… (More)
Is this relevant?
2013
2013
1. GTx-024, a novel selective androgen receptor modulator, is currently being investigated as an oral treatment for muscle… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Review
2013
Review
2013
PURPOSE OF REVIEW This review highlights selective androgen receptor modulators (SARMs) as emerging agents in late-stage clinical… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND: Cachexia, also known as muscle wasting, is a complex metabolic condition characterized by loss of skeletal muscle and… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2011
2011
9022 Background: Cancer cachexia causes muscle wasting and leads to decline in physical function. NSCLC patients with weight loss… (More)
Is this relevant?
2011
2011
9117 Background: Cancer cachexia causes muscle wasting and decline in physical function. Studies show that NSCLC patients with… (More)
Is this relevant?